Maxim Labkowski
This time last year, several leading pharmaceutical companies announced major M&A deals to help fill their product lines, including Bristol-Myers Squibb (Bmmi) Proposed acquisitions of Karuna, RayzeBio and AbbVie’s (ABBV) Deals to buy ImmunoGen and Cerevel.
Which brings us to
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1347295696/image_1347295696.jpg?io=getty-c-w750
Source link